|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006142,
umls-concept:C0013216,
umls-concept:C0205160,
umls-concept:C0441767,
umls-concept:C0449438,
umls-concept:C0600558,
umls-concept:C0746922,
umls-concept:C1184738,
umls-concept:C1516213,
umls-concept:C1521733,
umls-concept:C1522449,
umls-concept:C1706163,
umls-concept:C2697524,
umls-concept:C2700445
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2010-9-13
|
|
pubmed:abstractText |
Neoadjuvant chemotherapy (NAC) generally induces significant changes in the pathologic extent of disease. This potential down-staging challenges the standard indications of adjuvant radiation therapy. We assessed the utility of lymph node irradiation (LNI) in breast cancer (BC) patients with pathologic N0 status (pN0) after NAC and breast-conserving surgery (BCS).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1879-355X
|
|
pubmed:author |
pubmed-author:BergesOscarO,
pubmed-author:BrainEtienneE,
pubmed-author:DaveauCarolineC,
pubmed-author:De la LandeBrigitteB,
pubmed-author:GardnerMiriamM,
pubmed-author:LabibAlainA,
pubmed-author:LasrySergeS,
pubmed-author:Le ScodanRomualdR,
pubmed-author:MoissonPatriciaP,
pubmed-author:StevensDeniseD,
pubmed-author:VilletteSylvianeS
|
|
pubmed:copyrightInfo |
2010 Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
78
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
337-42
|
|
pubmed:meshHeading |
pubmed-meshheading:20171795-Adult,
pubmed-meshheading:20171795-Aged,
pubmed-meshheading:20171795-Anthracyclines,
pubmed-meshheading:20171795-Axilla,
pubmed-meshheading:20171795-Breast Neoplasms,
pubmed-meshheading:20171795-Chemotherapy, Adjuvant,
pubmed-meshheading:20171795-Disease-Free Survival,
pubmed-meshheading:20171795-Female,
pubmed-meshheading:20171795-Follow-Up Studies,
pubmed-meshheading:20171795-Humans,
pubmed-meshheading:20171795-Lymph Node Excision,
pubmed-meshheading:20171795-Lymph Nodes,
pubmed-meshheading:20171795-Lymphatic Irradiation,
pubmed-meshheading:20171795-Mastectomy, Segmental,
pubmed-meshheading:20171795-Middle Aged,
pubmed-meshheading:20171795-Neoadjuvant Therapy,
pubmed-meshheading:20171795-Neoplasm Recurrence, Local,
pubmed-meshheading:20171795-Neoplasm Staging,
pubmed-meshheading:20171795-Radiotherapy Dosage,
pubmed-meshheading:20171795-Regression Analysis,
pubmed-meshheading:20171795-Retrospective Studies
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?
|
|
pubmed:affiliation |
Department of Radiation Oncology, Centre René Huguenin, Saint-Cloud, France.
|
|
pubmed:publicationType |
Journal Article
|
